These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21333629)
1. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method. Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629 [TBL] [Abstract][Full Text] [Related]
2. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors. Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925 [TBL] [Abstract][Full Text] [Related]
3. Peptidyl-prolyl isomerase inhibitors. Wang XJ; Etzkorn FA Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169 [TBL] [Abstract][Full Text] [Related]
4. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity. Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173 [TBL] [Abstract][Full Text] [Related]
5. A high-throughput screen for inhibitors of the prolyl isomerase, Pin1, identifies a seaweed polyphenol that reduces adipose cell differentiation. Mori T; Hidaka M; Ikuji H; Yoshizawa I; Toyohara H; Okuda T; Uchida C; Asano T; Yotsu-Yamashita M; Uchida T Biosci Biotechnol Biochem; 2014; 78(5):832-8. PubMed ID: 25035986 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/- mice. Fanghänel J; Akiyama H; Uchida C; Uchida T FEBS Lett; 2006 May; 580(13):3237-45. PubMed ID: 16697379 [TBL] [Abstract][Full Text] [Related]
7. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors. Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456 [TBL] [Abstract][Full Text] [Related]
8. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1. Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802 [TBL] [Abstract][Full Text] [Related]
9. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1. Jiang B; Pei D J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061 [TBL] [Abstract][Full Text] [Related]
10. Prolyl cis/trans isomerase signalling pathways in cancer. Theuerkorn M; Fischer G; Schiene-Fischer C Curr Opin Pharmacol; 2011 Aug; 11(4):281-7. PubMed ID: 21497135 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Pin1 inhibitory activity of thiazole derivatives. Zhao H; Cui G; Jin J; Chen X; Xu B Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510 [TBL] [Abstract][Full Text] [Related]
12. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909 [TBL] [Abstract][Full Text] [Related]
13. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Uchida T; Takamiya M; Takahashi M; Miyashita H; Ikeda H; Terada T; Matsuo Y; Shirouzu M; Yokoyama S; Fujimori F; Hunter T Chem Biol; 2003 Jan; 10(1):15-24. PubMed ID: 12573694 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors. Du L; Wang X; Cui G; Xu B Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256 [TBL] [Abstract][Full Text] [Related]
16. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors]. Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834 [TBL] [Abstract][Full Text] [Related]
17. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products. Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609 [TBL] [Abstract][Full Text] [Related]
18. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182 [TBL] [Abstract][Full Text] [Related]
19. Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions. He S; Li L; Jin R; Lu X J Med Chem; 2023 Jul; 66(14):9251-9277. PubMed ID: 37438908 [TBL] [Abstract][Full Text] [Related]
20. Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes? Bianchi M; Manco M Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]